Composition for improving, preventing, or treating bone diseases or metabolic diseases, including novel lactobacillus sakei cvl-001 strain and culture medium thereof
A technology of Lactobacillus sarkeri and metabolic diseases, applied in the direction of metabolic diseases, Lactobacillus, bone diseases, etc., can solve the problems of serious obesity and side effects of drugs, achieve the purpose of inhibiting weight gain, improving osteoporosis, preventing Or the effect of treating osteoporosis or obesity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment approach
[0102] Hereinafter, the present invention will be further described in detail through examples. However, the following examples are only for illustrating the present invention, and the scope of the present invention is not limited to the following examples.
[0103] Throughout this specification, unless otherwise stated, "%" used to express the concentration of a specific substance has the following meanings, that is, solid / solid is (weight / weight) %, solid / liquid is (weight / volume) %, liquid / liquid is (volume / volume)%.
Embodiment 1
[0104] Example 1. Isolation of bacterial strains
[0105] Freshly pickled kimchi was collected from all over the country, and the collected kimchi was stored at a temperature of 6±0.5° C. for 0 to 5 weeks and used as a kimchi sample for isolating lactic acid bacteria. 500 g of the above-mentioned kimchi was ground by a hand blender (handblender, Hanil Co, Korea), and sterilized water was added to the kimchi liquid filtered with sterile gauze in 10 1 to 10 7 Diluted sequentially. Thus, a dilution of 10 7 Fold the kimchi smear medium.
[0106] Apply the diluted kimchi liquid to add 2% calcium carbonate (CaCO 3 ) MRS medium (Difco Co., France), cultured at 30° C. for 48 hours, and isolated the strain that formed the transparent ring. Gram staining (Gram strain kit, BD Co., USA) and catalase test (Biomerieux Co., France) were performed on the isolated above strains to provisionally confirm Gram-positive and catalase-negative colonies for lactic acid bacteria.
[0107]Inocul...
Embodiment 2
[0108] Example 2. Identification of Lactic Acid Bacteria Strains
[0109] The finally screened Lactobacillus sakei CVL-001 was identified by 16S ribosomal RNA base sequence analysis. After the isolated strains were separated by pure water, they were sent to Solgent (Daejeon, South Korea) by refrigerated express in the state of MRS plate (plate) for entrustment, using 27F (5'-AGAGTTTGATCCTGGCTCAG-3') and 1492R (5'-GGTTACCTTGTTACGACTT -3') to perform 16S ribosomal RNA base sequence analysis with a universal primer set.
[0110] A total of 1439 bp base sequence was determined by the 16S ribosomal RNA coding base sequence of the above-mentioned Lactobacillus sarkeri CVL-001 strain, and the results are shown in Table 1.
[0111] Table 1
[0112]
[0113]
[0114] Based on the above-mentioned nucleotide sequence executed, the homology detection of the nucleotide sequence was performed using the registration information (GeneBank database) as the object by the Blast program (...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com